Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Stelloo, E.

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(1 - 20 of 30)

Pages

Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer
Formalin-fixed, paraffin-embedded-targeted locus capture
Clinicogenomic associations in childhood Langerhans cell histiocytosis
Microcystic elongated and fragmented (MELF) pattern of invasion
Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer
Prognostic integrated image-based immune and molecular profiling in early-stage endometrial cancer
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing
Folate receptor-alpha targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative
Molecular alterations in endometrial cancer: implications for clinical management
Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
Comprehensive analysis of microsatellite instability and mismatch repair protein expression in nearly 700 endometrial cancers
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Pages